Arca Biopharma (ABIO) has released an update to notify the public and investors about its officers.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Raymond L. Woosley and Dan Mitchell have stepped down from ARCA biopharma’s board of directors, leading to an immediate reduction in the board size from eight to six members. Their resignations were amicable, with no disagreements cited regarding the company’s operations or policies. ARCA has acknowledged their valuable contributions during their tenure on the board.
For further insights into ABIO corporate activity, check out TipRanks’ Insiders Trading Activity page.
For a comprehensive understanding of the announcement, you can read the full document here.